Rosacea

JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis
atopic dermatitis
by NEXT STEPS IN DERM TEAM on
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …
Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea
rosacea
by NEXT STEPS IN DERM TEAM on
Rosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors and reducing inflammation with topical and oral therapies. Traditional therapies primarily focus on the papulopustular or background erythematotelangiectatic component of rosacea, leaving symptoms of flush …
Treating Redness and Facial Vessels with Lasers
rosacea
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Arisa Ortiz, director of laser and cosmetic dermatology at UC San Diego Health. Dr. Ortiz shares her tips in using lasers to treat rosacea and redness, which are common conditions she sees in her practice. Find out why setting patient expectations is especially important. Learn why looki …
JDD June 2023 Issue Highlights
acne
by NEXT STEPS IN DERM TEAM on
The June issue of the Journal of Drugs in Dermatology (JDD) features original articles with topics ranging from pediatric acne, rosacea, androgenetic alopecia, precision medicine, infantile hemangiomas, and many more.  Check out this month’s issue highlights straight from the JDD Editor’s desk: The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and …
Azelaic Acid Therapeutic Cheat Sheet
azelaic acid
by Kamaria Nelson, MD on
Azelaic acid is a topical therapeutic agent which is FDA approved to treat papules and pustules of mild to moderate rosacea and mild to moderate acne vulgaris.  It was first approved by the FDA in 1995 and since its approval, has been used for many off-label conditions including disorders of hyperpigmentation. Its utility in various conditions can be attributed to its anti-microbial, anti-inflamm …